Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics

Molecular Psychiatry
Joseph H LeeJ A Knowles

Abstract

Familial Alzheimer's disease (AD [MIM 104300]) has been a focus of intense investigation, primarily in Caucasian families from Europe and North America families. Although the late-onset form of familial AD, beginning after age 65 years, has been linked to regions on chromosomes 10q and 12p, the specific genetic variants have not yet been consistently identified. Using a unique cohort of families of Caribbean Hispanics ancestry, we screened the genome using 340 markers on 490 family members from 96 families with predominantly late-onset AD. We observed the strongest support for linkage on 18q (LOD=3.14). However, 17 additional markers (chromosomes 1-6, 8, 10, 12, and 14) exceeded a two-point LOD score of 1.0 under the affecteds-only autosomal dominant model or affected sibpair model. As we previously reported the fine-mapping effort on 12p showing modest evidence of linkage, we focused our fine-mapping efforts on two other candidate regions in the current report, namely 10q and 18q. We added 31 family members and eight additional Caribbean Hispanic families to fine map 10q and 18q. With additional microsatellite markers, the evidence for linkage for 18q strengthened near 112 cM, where the two-point LOD score for D18S541 was 3.37...Continue Reading

References

Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Jan 15, 1994·Genomics·P J TienariL Peltonen
Sep 1, 1994·The Journal of School Health·S H Terwilliger
May 9, 1997·Neuroscience Letters·F Wavrant-DeVrièzeM C Chartier-Harlin
Oct 23, 1997·JAMA : the Journal of the American Medical Association·M A Pericak-VanceJ L Haines
Apr 16, 1998·American Journal of Human Genetics·R S Spielman, W J Ewens
Mar 21, 1998·JAMA : the Journal of the American Medical Association·M X TangR Mayeux
Jun 23, 1998·American Journal of Human Genetics·J R O'Connell, D E Weeks
Aug 11, 1998·Nature Genetics·D BlackerR E Tanzi
Aug 26, 1998·JAMA : the Journal of the American Medical Association·E RogaevaP H St George-Hyslop
Aug 26, 1998·JAMA : the Journal of the American Medical Association·W S WuA Goate
Aug 27, 1998·American Journal of Human Genetics·K W BromanJ L Weber
Feb 5, 1999·Human Molecular Genetics·P KehoeM J Owen
Feb 18, 1999·JAMA : the Journal of the American Medical Association·W K ScottJ L Haines
Aug 12, 1999·American Journal of Human Genetics·S B RobertsK S Kendler
Feb 11, 2000·Neurology·R C DodelS M Paul
Mar 25, 2000·American Journal of Human Genetics·H H Göring, J D Terwilliger
Dec 13, 2000·Experimental Gerontology·M A Pericak-VanceJ L Haines
Nov 17, 2001·JAMA : the Journal of the American Medical Association·E S AthanR Mayeux
Nov 21, 2001·American Journal of Human Genetics·R MayeuxJ A Knowles
Mar 5, 2002·American Journal of Human Genetics·Yi-Ju LiMargaret A Pericak-Vance
Jun 5, 2002·Genome Research·W James KentDavid Haussler
Jul 23, 2002·Neuroscience Letters·Matthew D Martin-RehrmannG William Rebeck
Dec 20, 2002·Human Molecular Genetics·Deborah BlackerUNKNOWN NIMH Genetics Initiative Alzheimer's Disease Study Group
Feb 5, 2003·Human Molecular Genetics·Lindsay A FarrerClinton T Baldwin
Sep 11, 2003·Human Molecular Genetics·Aleister J SaundersDeborah Blacker
Oct 23, 2003·Human Molecular Genetics·Yi-Ju LiKathleen A Welsh-Bohmer

❮ Previous
Next ❯

Citations

Jan 16, 2007·Nature Genetics·Ekaterina RogaevaPeter St George-Hyslop
Oct 25, 2007·European Journal of Human Genetics : EJHG·Anna SillénCaroline Graff
Sep 8, 2010·Rejuvenation Research·Cristiano CapursoVincenzo Solfrizzi
Aug 19, 2006·Alzheimer Disease and Associated Disorders·Richard Mayeux
Dec 20, 2007·Alzheimer Disease and Associated Disorders·Richard Mayeux
Oct 17, 2007·Dementia and Geriatric Cognitive Disorders·Beverly JohnsonJoseph H Lee
Nov 7, 2007·BMC Neurology·Cynthia M BalionAfisi S Ismaila
Jun 8, 2006·Biology Direct·James L Weber
Jul 4, 2008·Pharmacogenomics·Meenal GuptaRitushree Kukreti
Feb 26, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesco BelliaEnrico Rizzarelli
Aug 1, 2011·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Suk Ling Ma, Linda Chiu Wa Lam
Jul 3, 2010·Neurobiology of Aging·Rita J GuerreiroJohn Hardy
Jul 31, 2007·Neurologic Clinics·Nilüfer Ertekin-Taner
Oct 13, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Rodney T PerryRodney C P Go
Jul 9, 2008·Annals of Medicine·Nathalie BrouwersChristine Van Broeckhoven
Aug 30, 2007·Human Molecular Genetics·Marian L HamshereMichael J Owen
Apr 22, 2005·Brain : a Journal of Neurology·Adriano Jimenez-EscrigSagrario Barquero
May 27, 2021·Nature Communications·Zihuai HeIuliana Ionita-Laza
Apr 3, 2007·Neurobiology of Aging·Davis RymanBruce T Lamb
Jun 6, 2009·Ageing Research Reviews·Davide SeripaAlberto Pilotto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Related Papers

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Daniel W HahsJonathan L Haines
American Journal of Medical Genetics
Amanda MyersAlison Goate
Human Molecular Genetics
Patrick G KehoeMichael J Owen
© 2022 Meta ULC. All rights reserved